TLThuy LeMD, DPhilSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Transmitted drug resistance and impact on long-term clinical outcomes in the VMVN clinical trial in Hanoi, Vietnam- Thuy LeView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Derivation of population mixing patterns from virus sequence data and their impacts on the modelling of HIV epidemics in MSM- Ngai Sze WongView Slideset
NPNittaya PhanuphakMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018David Cooper Memorial Lecture: Current effort to control the epidemic in the region- Nittaya Phanuphak, MD, PhDView Slideset
NPNicholas PatonMD, FRCPSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Treatment regimens for the public health approach – do we need to change?- Nicholas Paton, MD, FRCPView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018IP and regulatory barriers to access ART and drugs for co-infections in LMICs- Leena MenghaneyView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018WHO’s regional strategies- Polin Chan, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2018Professor David Cooper Tribute Eulogy- Praphan Phanuphak, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAsian Conference on Hepatitis and AIDS (ACHA) 2018Non-alcoholic fatty liver disease in China- Jiangao Fan, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAsian Conference on Hepatitis and AIDS (ACHA) 2018Sequential cross-section study on hepatitis viruses infection in Chinese AIDS patients- Lin Liu, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAsian Conference on Hepatitis and AIDS (ACHA) 2018New indicators for the evaluation of hepatitis B therapy- Xinxin Zhang, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAsian Conference on Hepatitis and AIDS (ACHA) 2018HIV-1/HCV co-infection treatment with single-tablet antiviral regimens (CoSTARs): 12 Weeks of Ledipasvir/ Sofosbuvir (LDV/SOF) after randomized switch to Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir alafenamide (E/C/F/TAF) or rilpivirin- Damian MccollView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAsian Conference on Hepatitis and AIDS (ACHA) 2018Efficacy and tolerability of grazoprevir and elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV and HIV co-infection: A nonrandomised, open-label clinical trial- Chien-Yu ChengView Slideset
